Listed

Xtant Medical Holdings, Inc.

XTNTNYSECIK 1453593HealthcareFiscal year ends Dec 31

Reports and events: 545 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Xtant Medical Holdings, Inc., Reports and events
FiledFormWhat it isAccession number
2023-08-1016:32 ET8-K1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-23-027585
2023-08-0909:04 ET8-K8.01 Other events0001493152-23-027280
2023-08-0316:59 ETSC 13D/AOwnership report, active investor, amended0000947871-23-000815
2023-08-0107:20 ET10-QQuarterly reportPeriod 2023-06-300001493152-23-026162
2023-08-0107:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-23-026160
2023-07-2816:06 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-23-025869
2023-07-2809:02 ET8-K5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001493152-23-025769
2023-07-1116:25 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001493152-23-024228
2023-07-0308:28 ET8-K1.01 Entry into a material agreement; 2.02 Results of operations; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-23-023229
2023-06-2008:58 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001493152-23-021783
2023-06-0818:00 ETDEF 14AProxy statementPeriod 2023-06-070001493152-23-020490
2023-05-1916:15 ET8-K5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001493152-23-018330
2023-05-1808:15 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-23-018040
2023-05-1616:15 ET8-K/A9.01 Financial statements and exhibits0001493152-23-017793
2023-05-0511:14 ETSC 13D/AOwnership report, active investor, amended0000947871-23-000526
2023-05-0407:20 ET10-QQuarterly reportPeriod 2023-03-310001493152-23-015374
2023-05-0407:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-23-015373
2023-05-0407:10 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001493152-23-015371
2023-03-0707:30 ET10-KAnnual reportPeriod 2022-12-310001493152-23-006881
2023-03-0707:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-23-006880
2023-03-0116:15 ET8-K1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-23-006396
2023-02-0109:00 ET8-K8.01 Other events0001493152-23-003251
2023-01-0908:15 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-23-000906
2022-11-0307:15 ET10-QQuarterly reportPeriod 2022-09-300001493152-22-030284
2022-11-0307:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-22-030277
2022-10-2816:15 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001493152-22-029849
2022-10-1108:15 ET8-K3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-22-028040
2022-09-2006:30 ETDEF 14AProxy statementPeriod 2022-09-200001493152-22-026308
2022-09-0614:19 ETSC 13DOwnership report, active investor0001104659-22-097801
2022-08-3108:15 ET8-K3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-22-024444
2022-08-3016:37 ETSC 13D/AOwnership report, active investor, amended0000947871-22-000940
2022-08-2408:15 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-22-023900
2022-08-0407:20 ET10-QQuarterly reportPeriod 2022-06-300001493152-22-021237
2022-08-0407:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-22-021233
2022-05-0508:16 ET10-QQuarterly reportPeriod 2022-03-310001493152-22-012170
2022-05-0508:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-22-012168
2022-05-0208:15 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001493152-22-011719
2022-03-0807:15 ET10-KAnnual reportPeriod 2021-12-310001493152-22-006240
2022-03-0807:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-22-006238
2022-01-0308:15 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-22-000042
2021-11-1207:30 ET10-QQuarterly reportPeriod 2021-09-300001493152-21-028011
2021-11-1207:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-21-028005
2021-08-0507:31 ET10-QQuarterly reportPeriod 2021-06-300001493152-21-018670
2021-08-0507:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-21-018666
2021-07-2806:45 ET8-K5.07 Shareholder vote results0001493152-21-017923
2021-06-1408:00 ETDEF 14AProxy statementPeriod 2021-06-140001493152-21-014227
2021-05-2008:44 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-21-012322
2021-05-1107:30 ET10-QQuarterly reportPeriod 2021-03-310001493152-21-010949
2021-05-1107:15 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-21-010948
2021-05-0616:15 ET8-K1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001493152-21-010620

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:08 ET. Listed shows no prices and gives no investment advice.